FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149168537> ?p ?o ?g. }

• W2149168537 endingPage "2272" @default.
• W2149168537 startingPage "2264" @default.
• W2149168537 abstract "Etanercept has been shown to improve the articular and cutaneous manifestations of psoriatic arthritis (PsA). In this study, we further evaluated the safety, efficacy, and effect on radiographic progression of etanercept in patients with PsA.Patients with PsA (n = 205) were randomized to receive placebo or 25 mg etanercept subcutaneously twice weekly for 24 weeks. Patients continued to receive blind-labeled therapy in a maintenance phase until all had completed the 24-week phase, then could receive open-label etanercept in a 48-week extension. Efficacy and safety were evaluated at 4, 12, and 24 weeks and at 12-week intervals thereafter. Radiographs of the hands and wrists were assessed at baseline and 24 weeks, at entry to the open-label phase, and after 48 weeks in the study.Etanercept significantly reduced the signs and symptoms of PsA and psoriasis. At 12 weeks, 59% of etanercept patients met the American College of Rheumatology 20% improvement criteria for joint response, compared with 15% of placebo patients (P < 0.0001), and results were sustained at 24 and 48 weeks. At 24 weeks, 23% of etanercept patients eligible for psoriasis evaluation achieved at least 75% improvement in the Psoriasis Area and Severity Index, compared with 3% of placebo patients (P = 0.001). Radiographic disease progression was inhibited in the etanercept group at 12 months; the mean annualized rate of change in the modified total Sharp score was -0.03 unit, compared with +1.00 unit in the placebo group (P = 0.0001). Etanercept was well tolerated.Etanercept reduced joint symptoms, improved psoriatic lesions, inhibited radiographic progression, and was well tolerated in patients with PsA." @default.
• W2149168537 created "2016-06-24" @default.
• W2149168537 creator A5007368461 @default.
• W2149168537 creator A5008717372 @default.
• W2149168537 creator A5038322725 @default.
• W2149168537 creator A5045706732 @default.
• W2149168537 creator A5054591042 @default.
• W2149168537 creator A5057538503 @default.
• W2149168537 creator A5075067451 @default.
• W2149168537 creator A5081778211 @default.
• W2149168537 creator A5082669130 @default.
• W2149168537 creator A5087679577 @default.
• W2149168537 date "2004-01-01" @default.
• W2149168537 modified "2023-10-16" @default.
• W2149168537 title "Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression" @default.
• W2149168537 cites W1976217778 @default.
• W2149168537 cites W1985004174 @default.
• W2149168537 cites W1997192647 @default.
• W2149168537 cites W2000652739 @default.
• W2149168537 cites W2003860570 @default.
• W2149168537 cites W2007517418 @default.
• W2149168537 cites W2008223306 @default.
• W2149168537 cites W2019225841 @default.
• W2149168537 cites W2025317527 @default.
• W2149168537 cites W2048860421 @default.
• W2149168537 cites W2059468409 @default.
• W2149168537 cites W2065563091 @default.
• W2149168537 cites W2066243006 @default.
• W2149168537 cites W2067327580 @default.
• W2149168537 cites W2075300112 @default.
• W2149168537 cites W2088158803 @default.
• W2149168537 cites W2098767548 @default.
• W2149168537 cites W2145696454 @default.
• W2149168537 cites W2156796142 @default.
• W2149168537 cites W2159106700 @default.
• W2149168537 cites W2167905575 @default.
• W2149168537 cites W2168698481 @default.
• W2149168537 cites W2206746226 @default.
• W2149168537 cites W2314052274 @default.
• W2149168537 cites W2328587823 @default.
• W2149168537 cites W2340084730 @default.
• W2149168537 cites W2480036115 @default.
• W2149168537 cites W4211046919 @default.
• W2149168537 doi "https://doi.org/10.1002/art.20335" @default.
• W2149168537 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15248226" @default.
• W2149168537 hasPublicationYear "2004" @default.
• W2149168537 type Work @default.
• W2149168537 sameAs 2149168537 @default.
• W2149168537 citedByCount "806" @default.
• W2149168537 countsByYear W21491685372012 @default.
• W2149168537 countsByYear W21491685372013 @default.
• W2149168537 countsByYear W21491685372014 @default.
• W2149168537 countsByYear W21491685372015 @default.
• W2149168537 countsByYear W21491685372016 @default.
• W2149168537 countsByYear W21491685372017 @default.
• W2149168537 countsByYear W21491685372018 @default.
• W2149168537 countsByYear W21491685372019 @default.
• W2149168537 countsByYear W21491685372020 @default.
• W2149168537 countsByYear W21491685372021 @default.
• W2149168537 countsByYear W21491685372022 @default.
• W2149168537 countsByYear W21491685372023 @default.
• W2149168537 crossrefType "journal-article" @default.
• W2149168537 hasAuthorship W2149168537A5007368461 @default.
• W2149168537 hasAuthorship W2149168537A5008717372 @default.
• W2149168537 hasAuthorship W2149168537A5038322725 @default.
• W2149168537 hasAuthorship W2149168537A5045706732 @default.
• W2149168537 hasAuthorship W2149168537A5054591042 @default.
• W2149168537 hasAuthorship W2149168537A5057538503 @default.
• W2149168537 hasAuthorship W2149168537A5075067451 @default.
• W2149168537 hasAuthorship W2149168537A5081778211 @default.
• W2149168537 hasAuthorship W2149168537A5082669130 @default.
• W2149168537 hasAuthorship W2149168537A5087679577 @default.
• W2149168537 hasConcept C126322002 @default.
• W2149168537 hasConcept C141071460 @default.
• W2149168537 hasConcept C142724271 @default.
• W2149168537 hasConcept C16005928 @default.
• W2149168537 hasConcept C198451711 @default.
• W2149168537 hasConcept C204787440 @default.
• W2149168537 hasConcept C27081682 @default.
• W2149168537 hasConcept C2776260265 @default.
• W2149168537 hasConcept C2777011040 @default.
• W2149168537 hasConcept C2777077863 @default.
• W2149168537 hasConcept C2777226972 @default.
• W2149168537 hasConcept C2777575956 @default.
• W2149168537 hasConcept C2780564577 @default.
• W2149168537 hasConcept C71924100 @default.
• W2149168537 hasConceptScore W2149168537C126322002 @default.
• W2149168537 hasConceptScore W2149168537C141071460 @default.
• W2149168537 hasConceptScore W2149168537C142724271 @default.
• W2149168537 hasConceptScore W2149168537C16005928 @default.
• W2149168537 hasConceptScore W2149168537C198451711 @default.
• W2149168537 hasConceptScore W2149168537C204787440 @default.
• W2149168537 hasConceptScore W2149168537C27081682 @default.
• W2149168537 hasConceptScore W2149168537C2776260265 @default.
• W2149168537 hasConceptScore W2149168537C2777011040 @default.
• W2149168537 hasConceptScore W2149168537C2777077863 @default.
• W2149168537 hasConceptScore W2149168537C2777226972 @default.
• W2149168537 hasConceptScore W2149168537C2777575956 @default.

• next